01099 國藥控股
公司資料 - 財務狀況表
國藥控股股份有限公司 股票編號: 01099
SINOPHARM GROUP CO. LTD. 集團網址: http://www.sinopharmgroup.com.cn
非流動資產
2024/12 - 末期
人民幣(K¥)
與去年末期
比較
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
投資物業393,033-21.623%501,466538,338588,366634,050
物業、廠房、設備及其他12,386,202-0.761%12,481,23412,616,76612,424,34212,067,755
租賃土地7,246,238-2.295%7,416,4237,030,3986,983,4106,828,091
無形資產8,948,873-12.233%10,196,14910,170,91910,391,72710,729,302
聯營公司及共同控制公司權益10,167,8554.707%9,710,7668,987,6518,414,6797,770,772
其他非流動資產6,241,472-0.196%6,253,7066,024,6805,687,6565,596,763
45,383,673-2.526%46,559,74445,368,75244,490,18043,626,733
存貨62,352,8123.873%60,027,64860,925,83151,499,62547,085,450
 
流動資產
現金及銀行結存54,313,359-14.881%63,808,53855,221,62443,529,42850,178,265
其他流動資產230,781,4008.349%212,998,914203,258,927195,893,088170,326,913
持作出售資產0--00019,345
347,447,5713.151%336,835,100319,406,382290,922,141267,609,973
 
流動負債
其他流動負債250,375,5883.679%241,490,637234,962,957219,306,549203,977,099
持作出售資產相關負債0--0000
250,375,5883.679%241,490,637234,962,957219,306,549203,977,099
流動資產淨值97,071,9831.812%95,344,46384,443,42571,615,59263,632,874
資產總額減流動負債142,455,6560.389%141,904,207129,812,177116,105,772107,259,607
 
非流動負債
15,768,354-26.949%21,585,46219,742,98716,451,83717,312,286
 
資本及儲備
   股本3,120,6560.000%3,120,6563,120,6563,120,6563,120,656
   儲備75,763,1396.019%71,461,56164,947,90358,765,35953,238,189
   其他0--0000
股東資金78,883,7955.768%74,582,21768,068,55961,886,01556,358,845
非控股權益47,803,5074.519%45,736,52842,000,63137,767,92033,588,476
其他0--0000
126,687,3025.293%120,318,745110,069,19099,653,93589,947,321
 
承擔及或然負債
承擔----257,311447,396590,396217,198
或然負債----0000
 

Copyright © 2025 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.